Baltimore Eye Surgery Blog
How an eye surgeon can help after an eye injury
Submitted by Elman Retina Group on June 27, 2016
At Elman Retina Group, our goal is to provide you with exceptional, individualized care. If you’ve suffered any type of eye injury, it’s important to have an experienced eye surgeon take a closer look at your eyes, even if your current physician or another medical provider has treated you for immediate needs. The level of…Read More→
What is a Retinal Tear and How can an Eye Surgeon Help?
Submitted by Elman Retina Group on June 22, 2016
Retinal tears occur when the clear jelly filling the middle of your eye called the vitreous humor shifts and pulls on your retina. Sometimes, simple aging causes retinal tears while advanced diabetes or trauma to the eye may force the retina to slide, pull on and damage the retina. Retinal tears occurring beside a blood…Read More→
How Your Retina Specialist Can Help with Age Related Eye Diseases
Submitted by Elman Retina Group on May 31, 2016
Are you getting older and are concerned about your vision? Whether you are starting to have symptoms of an age-related eye disease or you want to keep your eyes as healthy as possible as you age, our ophthalmologists at Elman Retina Group can help. Common Age-Related Eye Diseases Seniors over the age of 60 are especially susceptible…Read More→
What to do When You Suffer From an Ocular Trauma
Submitted by Elman Retina Group on March 30, 2016
Protective eyewear can keep most foreign objects from your eyes during obvious dangerous situations, but you can’t protect from every possible case of ocular trauma. Everyone gets something in their eye sometime during their life, whether it’s an eyelash or piece of sand or something much more serious. Your response to the problem can determine…Read More→
When is Eye Surgery a Necessity?
Submitted by Elman Retina Group on February 29, 2016
When dealing with most eye conditions, treatment consists of eye drops, other medication, and sometimes eye exercises. As time goes on, your condition may worsen to the point where medication doesn’t work any more. Once this begins to affect your quality of life, it may be time to speak with our doctors about having eye…Read More→
What is wet AMD (wet macular degeneration)?
Submitted by Elman Retina Group on January 28, 2016
The number one cause of vision loss is a condition known as age-related macular degeneration (AMD). It’s been estimated that as many as 10 million people in the United States are currently dealing with this disease. AMD and the Eye The back of your eye is lined with a delicate tissue called the retina. The…Read More→
What are the differences between Macular Holes and Macular Degeneration?
Submitted by Elman Retina Group on January 20, 2016
Inside your eyes, there is a thin tissue along the back of the inner surface called the retina, which collects visual images and sends this information up the optic nerves to the brain. The macula is a spot at the center of the retina, and is necessary for performing focusing tasks such as reading fine…Read More→
What is Central Retinal Artery Occlusion?
Submitted by Elman Retina Group on January 18, 2016
First described in 1859, central retinal artery occlusion occurs when the central artery that supplies blood to the retina becomes blocked. (The retina is a thin tissue on the back of the inner eye that gathers visual images). The most common cause of an arterial block is an embolus. Emboli are clots (often formed by…Read More→
Treatment of diabetic patients undergoing monthly treatment with Lucentis
Submitted by Elman Retina Group on December 3, 2015
This was the poster Dr. Elman presented at the annual meeting of the American Academy of Ophthalmology held in Las Vegas two weeks ago. The poster shows that treatment of diabetic patients undergoing monthly treatment with Lucentis for diabetic macular edema unexpectedly benefited from improvement in their severity of diabetic retinopathy. Essentially, Lucentis treatment “turned…Read More→
Lucentis effective for proliferative diabetic retinopathy
Submitted by Elman Retina Group on November 13, 2015
Elman Retina Group key center in NIH-funded clinical trial – marks first major advance in therapy in 40 years A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) compared Lucentis with a type of…Read More→
